98%
921
2 minutes
20
Post-stroke optogenetic stimulation has been shown to enhance neurovascular coupling and functional recovery. Neuronal nitric oxide synthase (nNOS) has been implicated as a key regulator of the neurovascular response in acute stroke; however, its role in subacute recovery remains unclear. We investigated the expression of nNOS in stroke mice undergoing optogenetic stimulation of the contralesional lateral cerebellar nucleus (cLCN). We also examined the effects of nNOS inhibition on functional recovery using a pharmacological inhibitor targeting nNOS. Optogenetically stimulated stroke mice demonstrated significant improvement on the horizontal rotating beam task at post-stroke days 10 and 14. nNOS mRNA and protein expression was significantly and selectively decreased in the contralesional primary motor cortex (cM1) of cLCN-stimulated mice. The nNOS expression in cM1 was negatively correlated with improved recovery. nNOS inhibitor (ARL 17477)-treated stroke mice exhibited a significant functional improvement in speed at post-stroke day 10, when compared to stroke mice receiving vehicle (saline) only. Our results show that optogenetic stimulation of cLCN and systemic nNOS inhibition both produce functional benefits after stroke, and suggest that nNOS may play a maladaptive role in post-stroke recovery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925487 | PMC |
http://dx.doi.org/10.1007/s12975-020-00831-y | DOI Listing |
Mol Ther Methods Clin Dev
September 2025
Neuroscience Research Australia, Sydney, NSW 2031, Australia.
Optogenetics offers a minimally invasive, low-fatigue, and temporally precise alternative to electrical stimulation for skeletal muscle control. After opsin expression in muscle cells, contraction can be stimulated with light. Obstructive sleep apnea, characterized by repeated airway collapse during sleep, suits this approach, as upper airway muscles are readily accessible via the oral cavity, and require stimulation synchronized to respiration.
View Article and Find Full Text PDFMol Metab
September 2025
Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA. Electronic address:
Background And Objective: Connexin43 (Cx43), encoded by Gja1, forms gap junctions between adjacent cells. In adipose tissue, it is upregulated during adipose beiging while downregulated by high-fat-diet (HFD) feeding. Adipocyte-specific Gja1 overexpression enhances adipose tissue beiging in response to mild cold stress of room temperature.
View Article and Find Full Text PDFNeuroscience
September 2025
Institute of Physiology of the Czech Academy of Sciences, Videnska 1830, 14200 Prague 4, Czech Republic.
Impairments in decision-making and behavioral flexibility in patients with schizophrenia (SCZ) are currently among the most investigated aspects of SCZ. Increased GLUergic excitatory activity and decreased GABAergic inhibitory activity induce mPFC-vHPC γ/θ band desynchronization in many tasks where behavioral flexibility is tested. However, these tasks used "perceptual" decision-making/flexibility but not navigational decision-making/flexibility.
View Article and Find Full Text PDFJ Neural Eng
September 2025
Department of Computer Science and Engineering College of Engineering, University of Washington, Box 352350, Seattle, WA 98195-2350, USA, Seattle, Washington, 98105, UNITED STATES.
Unlabelled: Closed-loop neural stimulation provides novel therapies for neurological diseases such as Parkinson's disease (PD), but it is not yet clear whether artificial intelligence (AI) techniques can tailor closed-loop stimulation to individual patients or identify new therapies. Further advancements are required to address a number of difficulties with translating AI to this domain, including sample efficiency, training time, and minimizing loop latency such that stimulation may be shaped in response to changing brain activity.
Approach: we propose temporal basis function models (TBFMs) to address these difficulties, and explore this approach in the context of excitatory optogenetic stimulation.
Small Methods
September 2025
Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, School of Biomedical Engineering, National Center for Translational Medicine, National Engineering Research Center of Advanced Magnetic Resonance Technologies for Diagnosis and Therapy, Shanghai Jiao
Neuromodulation is a highly promising technology for controlling neural circuits, treating nervous system diseases, and manipulating brain function. Conventional approaches, such as direct electrical stimulation or optogenetics, face challenges from their unstable therapeutic outcomes, invasive nature, and potential tissue damage. The emergence of stimuli-responsive nanomaterial-based wireless neuromodulation techniques offers tunability, minimal invasiveness, highly specific targeting, and long-term biocompatibility and stability.
View Article and Find Full Text PDF